1h
Hosted on MSNWall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What’s Next?Merck & Co. (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name ...
It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...
10h
Zacks.com on MSNPharma Stock Roundup: PFE, LLY, NVO, LLY and AZN's Q4 Earnings UpdateThis week was loaded with earnings releases of many large drugmakers. Novo Nordisk NVO, Merck MRK, Pfizer PFE, Eli Lilly LLY, ...
Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...
Topical steroid withdrawal syndrome may signal a reminder to clinicians to be good stewards of topical treatments, according ...
RBC Capital Markets analyst Bish Koziol made eight changes to his quantitatively driven top 40 list of stock picks. Maple ...
Check out the latest brokerage calls and analyst comments on the stocks in action today. Our coverage includes Bharti Airtel, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results